France Stomach Cancer Treatment Market Size & Outlook

The stomach cancer treatment market in France is expected to reach a projected revenue of US$ 420.4 million by 2030. A compound annual growth rate of 15.7% is expected of France stomach cancer treatment market from 2025 to 2030.
Revenue, 2024 (US$M)
$164.4
Forecast, 2030 (US$M)
$420.4
CAGR, 2025 - 2030
15.7%
Report Coverage
France

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France stomach cancer treatment market, 2018-2030 (US$M)

France stomach cancer treatment market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

France stomach cancer treatment market highlights

  • The France stomach cancer treatment market generated a revenue of USD 164.4 million in 2024 and is expected to reach USD 420.4 million by 2030.
  • The France market is expected to grow at a CAGR of 15.7% from 2025 to 2030.
  • In terms of segment, targeted therapy was the largest revenue generating treatment type in 2024.
  • Immunotherapy is the most lucrative treatment type segment registering the fastest growth during the forecast period.

Stomach cancer treatment market data book summary

Market revenue in 2024USD 164.4 million
Market revenue in 2030USD 420.4 million
Growth rate15.7% (CAGR from 2025 to 2030)
Largest segmentTargeted therapy
Fastest growing segmentImmunotherapy
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationStandard Chemotherapy, Targeted Therapy, Immunotherapy
Key market players worldwideNovartis AG ADR, Pfizer Inc, Viatris Inc, Roche Holding AG ADR, Eli Lilly and Co, Merck & Co Inc, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb Co, Celltrion Healthcare, Samsung Bioepis

Other key industry trends

  • In terms of revenue, France accounted for 3.1% of the global stomach cancer treatment market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, UK stomach cancer treatment market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 577.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Stomach Cancer Treatment Market Companies

Name Profile # Employees HQ Website
Samsung Bioepis View profile 501-1000 Incheon, Inch'on-jikhalsi, South Korea, Asia https://www.samsungbioepis.com
Celltrion Healthcare View profile 51-100 Incheon, Inch'on-jikhalsi, South Korea, Asia http://www.celltrionhealthcare.com/
Viatris Inc View profile 38000 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 https://www.viatris.com
Eli Lilly and Co View profile 43000 Lilly Corporate Center, Indianapolis, IN, United States, 46285 https://www.lilly.com
Bristol-Myers Squibb Co View profile 34100 Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 https://www.bms.com
Merck & Co Inc View profile 72000 126 East Lincoln Avenue, Rahway, NJ, United States, 07065 https://www.merck.com
Pfizer Inc View profile 88000 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 https://www.pfizer.com
Roche Holding AG ADR View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

France stomach cancer treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stomach cancer treatment market will help companies and investors design strategic landscapes.


Targeted therapy was the largest segment with a revenue share of 50.61% in 2024. Horizon Databook has segmented the France stomach cancer treatment market based on standard chemotherapy, targeted therapy, immunotherapy covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to France stomach cancer treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France stomach cancer treatment market databook

  • Our clientele includes a mix of stomach cancer treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France stomach cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into France stomach cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France stomach cancer treatment market size, by treatment type, 2018-2030 (US$M)

France Stomach Cancer Treatment Market Outlook Share, 2024 & 2030 (US$M)

France stomach cancer treatment market size, by treatment type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online